๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Prevention of de novo prostate cancer by immunization with tumor-derived vaccines

โœ Scribed by Mark A. Suckow; William R. Wolter; Morris Pollard


Book ID
105966839
Publisher
Springer-Verlag
Year
2005
Tongue
English
Weight
350 KB
Volume
54
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Tumor-specific CD8+ T lymphocytes derive
โœ Franck Housseau; Daniel A. Langer; Samuel D. Oberholtzer; Anitha Moorthy; Hyam I ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 150 KB ๐Ÿ‘ 2 views

## Abstract To identify tumorโ€associated antigens as putative targets for developing immunotherapies against prostate cancer, we investigated the ability of T cells derived from the peripheral blood lymphocytes of prostate cancer patients to recognize autologous tumor cells. The technical challenge

Identification of colon-tumor-associated
โœ Janet H. Ransom; Barbara A. Pelle; Henk Hubers; Linette M. Keynton; Michael G. H ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 953 KB

## Abstract Tumor immunity developing as a response to an autologous colonโ€tumor/bacillus Calmetteโ€Guerin (BCG) vaccine appears to be associated with induction of CD4 helper T cells, implied by the observation that vaccine efficacy is associated with major histocompatibility complex classโ€ll molecu